1,417
Views
10
CrossRef citations to date
0
Altmetric
Report

Epitope characterization of anti-JAM-A antibodies using orthogonal mass spectrometry and surface plasmon resonance approaches

, , , , , , , & show all
Pages 1317-1326 | Received 31 May 2017, Accepted 11 Sep 2017, Published online: 16 Oct 2017

References

  • Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol. 2010;10:345-52. doi:10.1038/nri2747. PMID:20414207
  • Beck A, Goetsch L, Dumontet C, Corvaïa N. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. doi:10.1038/nrd.2016.268. PMID:28303026
  • Reichert JM. Antibodies to watch in 2017. MAbs. 2017;9(2):167-181. doi:10.1080/19420862.2016.1269580. PMID:27960628
  • Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianférani S. Characterization of therapeutic antibodies and related products. Analytical Chem. 2012;85:715-36. doi:10.1021/ac3032355.
  • Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv. 2012;30:210-22. doi:10.1016/j.biotechadv.2011.05.006. PMID:21619926
  • Peng L, Oganesyan V, Damschroder MM, Wu H, Dall'Acqua WF. Structural and functional characterization of an agonistic anti-human EphA2 monoclonal antibody. J Mol Biol. 2011;413:390-405. doi:10.1016/j.jmb.2011.08.018. PMID:21867711
  • Ahn J, Engen JR. The use of hydrogen/deuterium exchange mass spectrometry in epitope mapping. Chem Today. 2013;31:25-8
  • Ultsch M, Bevers J, Nakamura G, Vandlen R, Kelley RF, Wu LC, Eigenbrot C. Structural basis of signaling blockade by anti-IL-13 antibody lebrikizumab. J Mol Biol. 2013;425:1330-9. doi:10.1016/j.jmb.2013.01.024. PMID:23357170
  • Wei H, Mo J, Tao L, Russell RJ, Tymiak AA, Chen G, Iacob RE, Engen JR. Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications. Drug Discovery Today. 2014;19:95-102. doi:10.1016/j.drudis.2013.07.019. PMID:23928097
  • Renaud JP, Chung CW, Danielson UH, Egner U, Hennig M, Hubbard RE, Nar H. Biophysics in drug discovery: impact, challenges and opportunities. Nat Rev Drug Discovery. 2016;15:679-98. doi:10.1038/nrd.2016.123. PMID:27516170
  • Jefferis R. Isotype and glycoform selection for antibody therapeutics. Arch Biochem Biophys. 2012;526:159-66. doi:10.1016/j.abb.2012.03.021. PMID:22465822
  • Zhang Y, Cui W, Wecksler AT, Zhang H, Molina P, Deperalta G, Gross ML. Native MS and ECD characterization of a fab–antigen complex may facilitate crystallization for X-ray diffraction. J Am Society Mass Spectrometry. 2016;27:1139-42. doi:10.1007/s13361-016-1398-9.
  • Donnarumma D, Faleri A, Costantino P, Rappuoli R, Norais N. The role of structural proteomics in vaccine development: recent advances and future prospects. Expert Rev Proteomics. 2016;13:55-68. doi:10.1586/14789450.2016.1121113. PMID:26714563
  • Berkowitz SA, Engen JR, Mazzeo JR, Jones GB. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nat Rev Drug Discovery. 2012;11:527-40. doi:10.1038/nrd3746. PMID:22743980
  • Beck A, Debaene F, Diemer H, Wagner‐Rousset E, Colas O, Dorsselaer AV, Cianférani S. Cutting‐edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. J Mass Spectrometry. 2015;50:285-97. doi:10.1002/jms.3554.
  • Atmanene C, Wagner-Rousset E, Malissard M, Chol B, Robert A, Corvaía N, Van Dorsselaer A, Beck A, Sanglier-Cianférani S. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. Analytical chemistry 2009;81:6364-73. doi:10.1021/ac9007557. PMID:19588976
  • Arthur KK, Gabrielson JP, Hawkins N, Anafi D, Wypych J, Nagi A, Sullivan JK, Bondarenko PV. In vitro stoichiometry of complexes between the soluble RANK ligand and the monoclonal antibody denosumab. Biochemistry. 2012;51:795-806. doi:10.1021/bi2007806. PMID:22242921
  • Dyachenko A, Wang G, Belov M, Makarov A, De Jong RN, Van Den Bremer ET, Parren PW, Heck AJ. Tandem native mass-spectrometry on antibody–drug conjugates and submillion Da antibody–antigen protein assemblies on an Orbitrap EMR equipped with a High-Mass Quadrupole Mass Selector. Anal Chem. 2015;87:6095-102. doi:10.1021/acs.analchem.5b00788. PMID:25978613
  • Wang G, de Jong RN, van den Bremer ET, Parren PW, Heck AJ. Enhancing accuracy in molecular weight determination of highly heterogeneously glycosylated proteins by native tandem mass spectrometry. Anal Chem. 2017;89(9):4793-4797. doi:10.1021/acs.analchem.6b05129. PMID:28383250
  • Leitner A, Joachimiak LA, Bracher A, Mönkemeyer L, Walzthoeni T, Chen B, Pechmann S, Holmes S, Cong Y, Ma B, et al. The molecular architecture of the eukaryotic chaperonin TRiC/CCT. Structure. 2012;20:814-25. doi:10.1016/j.str.2012.03.007. PMID:22503819
  • Hall Z, Schmidt C, Politis A. Uncovering the early assembly mechanism for amyloidogenic β2-microglobulin using cross-linking and native mass spectrometry. J Biol Chem. 2016;291(9):4626-37. doi:10.1074/jbc.M115.691063.
  • Lössl P, Sinz A. Combining amine-reactive cross-linkers and photo-reactive amino acids for 3D-structure analysis of proteins and protein complexes. Methods Mol Biol. 2016;1394:109-27. doi:10.1007/978-1-4939-3341-9_9. PMID:26700045
  • Xu G, Chance MR. Hydroxyl radical-mediated modification of proteins as probes for structural proteomics. Chem Rev. 2007;107:3514-43. doi:10.1021/cr0682047. PMID:17683160
  • Kiselar JG, Chance MR. Future directions of structural mass spectrometry using hydroxyl radical footprinting. J Mass Spectrometry. 2010;45:1373-82. doi:10.1002/jms.1808.
  • Wecksler AT, Kalo MS, Deperalta G. Mapping of fab-1: VEGF interface using carboxyl group footprinting mass spectrometry. J Am Society Mass Spectrometry. 2015;26:2077-80. doi:10.1007/s13361-015-1273-0.
  • Luchini A, Espina V, Liotta LA. Protein painting reveals solvent-excluded drug targets hidden within native protein–protein interfaces. Nat Communications. 2014;5:4413. doi:10.1038/ncomms5413.
  • Li J, Wei H, Krystek SR Jr, Bond D, Brender TM, Cohen D, Feiner J, Hamacher N, Harshman J, Huang RY, et al. Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis. Anal Chem. 2017;89(4):2250-2258. doi:10.1021/acs.analchem.6b03058.
  • Snijder J, Burnley RJ, Wiegard A, Melquiond AS, Bonvin AM, Axmann IM, Heck AJ. Insight into cyanobacterial circadian timing from structural details of the KaiB–KaiC interaction. Proc Natl Acad Sci. 2014;111:1379-84. doi:10.1073/pnas.1314326111. PMID:24474762
  • Premchandar A, Kupniewska A, Tarnowski K, Mücke N, Mauermann M, Kaus-Drobek M, Edelman A, Herrmann H, Dadlez M. Analysis of distinct molecular assembly complexes of keratin K8 and K18 by hydrogen–deuterium exchange. J Structural Biol. 2015;192:426-40. doi:10.1016/j.jsb.2015.10.001.
  • Chiu P-L, Bou-Assaf GM, Chhabra ES, Chambers MG, Peters RT, Kulman JD, Walz T. Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry. Blood. 2015;126:935-8. doi:10.1182/blood-2015-04-641688. PMID:26065652
  • Coales SJ, Tuske SJ, Tomasso JC, Hamuro Y. Epitope mapping by amide hydrogen/deuterium exchange coupled with immobilization of antibody, on‐line proteolysis, liquid chromatography and mass spectrometry. Rapid Communications Mass Spectrometry. 2009;23:639-47. doi:10.1002/rcm.3921.
  • Zhang Q, Willison LN, Tripathi P, Sathe SK, Roux KH, Emmett MR, Blakney GT, Zhang HM, Marshall AG. Epitope mapping of a 95 kDa antigen in complex with antibody by solution-phase amide backbone hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem. 2011;83:7129-36. doi:10.1021/ac201501z. PMID:21861454
  • Faleri A, Santini L, Brier S, Pansegrau W, Surdo PL, Scarselli M, Buricchi F, Volpini G, Genovese A, van der Veen S, et al. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties. FASEB J. 2014;28:1644-53. doi:10.1096/fj.13-239012. PMID:24371123
  • Casina VC, Hu W, Mao J-H, Lu R-N, Hanby HA, Pickens B, Kan ZY, Lim WK, Mayne L, Ostertag EM, et al. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome. Proc Natl Acad Sci. 2015;112:9620-5. doi:10.1073/pnas.1512561112. PMID:26203127
  • Bertoldi I, Faleri A, Galli B, Surdo PL, Liguori A, Norais N, Santini L, Masignani V, Pizza M, Giuliani MM. Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components. FASEB J. 2016;30:93-101. doi:10.1096/fj.15-273813. PMID:26304221
  • Zhang A, Hu P, MacGregor P, Xue Y, Fan H, Suchecki P, Olszewski L, Liu A. Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling. Anal Chem. 2014;86:3468-75. doi:10.1021/ac404130a. PMID:24597564
  • Visser J, Feuerstein I, Stangler T, Schmiederer T, Fritsch C, Schiestl M. Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab. BioDrugs. 2013;27:495-507. doi:10.1007/s40259-013-0036-3. PMID:23649935
  • Rose RJ, van Berkel PH, van den Bremer ET, Labrijn AF, Vink T, Schuurman J, Heck AJ, Parren PW. Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG. MAbs. 2013;5:219-28. doi:10.4161/mabs.23532. PMID:23406897
  • Zhang A, Fang J, Chou RY-T, Bondarenko PV, Zhang Z. Conformational difference in human IgG2 disulfide isoforms revealed by hydrogen/deuterium exchange mass spectrometry. Biochemistry. 2015;54:1956-62. doi:10.1021/bi5015216. PMID:25730439
  • Yan Y, Wei H, Fu Y, Jusuf S, Zeng M, Ludwig R, Krystek SR Jr, Chen G, Tao L, Das TK. Isomerization and oxidation in the complementarity-determining regions of a monoclonal antibody: a study of the modification–structure–function correlations by hydrogen–deuterium exchange mass spectrometry. Analytical Chem. 2016;88:2041-50. doi:10.1021/acs.analchem.5b02800.
  • Pandit D, Tuske SJ, Coales SJ, Liu A, Lee JE, Morrow JA, Nemeth JF, Hamuro Y. Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking. J Mol Recognition. 2012;25:114-24. doi:10.1002/jmr.1169.
  • Gribenko AV, Parris K, Mosyak L, Li S, Handke L, Hawkins JC, Severina E, Matsuka YV, Anderson AS. High Resolution Mapping of Bactericidal Monoclonal Antibody Binding Epitopes on Staphylococcus aureus Antigen MntC. PLoS Pathog. 2016;12:e1005908. doi:10.1371/journal.ppat.1005908. PMID:27689696
  • Zhang H, Cui W, Gross ML. Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies. FEBS Letters. 2014;588:308-17. doi:10.1016/j.febslet.2013.11.027. PMID:24291257
  • Iacob RE, Engen JR. Hydrogen exchange mass spectrometry: are we out of the quicksand? J Am Society Mass Spectrometry. 2012;23:1003-10. doi:10.1007/s13361-012-0377-z.
  • Pirrone GF, Iacob RE, Engen JR. Applications of hydrogen/deuterium exchange MS from 2012 to 2014. Analytical Chem. 2014;87:99-118. doi:10.1021/ac5040242.
  • Majumdar R, Middaugh CR, Weis DD, Volkin DB. Hydrogen–deuterium exchange mass spectrometry as an emerging analytical tool for stabilization and formulation development of therapeutic monoclonal antibodies. J Pharmaceutical Sci. 2015;104:327-45. doi:10.1002/jps.24224.
  • Malito E, Faleri A, Surdo PL, Veggi D, Maruggi G, Grassi E, Cartocci E, Bertoldi I, Genovese A, Santini L, et al. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci. 2013;110:3304-9. doi:10.1073/pnas.1222845110. PMID:23396847
  • Abbott WM, Damschroder MM, Lowe DC. Current approaches to fine mapping of antigen–antibody interactions. Immunology. 2014;142:526-35. doi:10.1111/imm.12284. PMID:24635566
  • Clementi N, Mancini N, Criscuolo E, Cappelletti F, Clementi M, Burioni R. Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis. Methods Mol Biol. 2014;1131:427-46. doi:10.1007/978-1-62703-992-5_26.
  • Hao G, Wesolowski JS, Jiang X, Lauder S, Sood VD. Epitope characterization of an anti‐PD‐L1 antibody using orthogonal approaches. J Mol Recognition. 2015;28:269-76. doi:10.1002/jmr.2418.
  • Prądzińska M, Behrendt I, Astorga-Wells J, Manoilov A, Zubarev RA, Kołodziejczyk AS, Rodziewicz-Motowidło S, Czaplewska P. Application of amide hydrogen/deuterium exchange mass spectrometry for epitope mapping in human cystatin C. Amino Acids. 2016;48:2809-20. doi:10.1007/s00726-016-2316-y. PMID:27573935
  • Goetsch L, Haeuw JF, Beau‐Larvor C, Gonzalez A, Zanna L, Malissard M, Lepecquet AM, Robert A, Bailly C, Broussas M, et al. A novel role for junctional adhesion molecule‐A in tumor proliferation: Modulation by an anti‐JAM‐A monoclonal antibody. Int J Cancer. 2013;132:1463-74. doi:10.1002/ijc.27772. PMID:22886345
  • Debaene F, Wagner-Rousset E, Colas O, Ayoub D, Corvaïa N, Van Dorsselaer A, Beck A, Cianférani S. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and “bispecific” monoclonal antibody formation. Anal Chem. 2013;85:9785-92. doi:10.1021/ac402237v. PMID:24007193
  • Babinska A, Kedees MH, Athar H, Sobocki T, Sobocka MB, Ahmed T, Ehrlich YH, Hussain MM, Kornecki E. Two Regions of the Human Platelet F11-Receptor (F11R) Are Critical for Platelet Aggregation, Potentiation and Adhesion*. Thrombosis Haemostasis. 2002;87:712-21. PMID:12008956
  • Mandell KJ, McCall IC, Parkos CA. Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J Biol Chem. 2004;279:16254-62. doi:10.1074/jbc.M309483200. PMID:14749337
  • Prota AE, Campbell JA, Schelling P, Forrest JC, Watson MJ, Peters TR, Aurrand-Lions M, Imhof BA, Dermody TS, Stehle T. Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci. 2003;100:5366-71. doi:10.1073/pnas.0937718100. PMID:12697893
  • Krayukhina E, Noda M, Ishii K, Maruno T, Wakabayashi H, Tada M, Suzuki T, Ishii-Watabe A, Kato M, Uchiyama S. Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments. MAbs. 2017;9(4):664-679. 1-16. doi:10.1080/19420862.2017.1297909. PMID:28387583
  • Beck A, Bussat M-C, Zorn N, Robillard V, Klinguer-Hamour C, Chenu S, Goetsch L, Corvaïa N, Van Dorsselaer A, Haeuw JF. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. J Chromatography B. 2005;819:203-18. doi:10.1016/j.jchromb.2004.06.052.
  • Hourdel V, Volant S, O'Brien DP, Chenal A, Chamot-Rooke J, Dillies M-A, Brier S. MEMHDX: an interactive tool to expedite the statistical validation and visualization of large HDX-MS datasets. Bioinformatics. 2016;32:3413-9. PMID:27412089

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.